Clinical Trials Directory

Trials / Completed

CompletedNCT00607737

Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes

Doubleblind, Randomised, Single Centre Investigator Sponsored Study of Applications Site Reactions After Deep and Superficial Subcutaneous and Intradermal Injection of Insulin Detemir and Saline in Subjects With Diabetes Mellitus

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Lise Tarnow · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To compare application site reactions after superficial and deep subcutaneous and intradermal injections of insulin detemir and saline in patients with diabetes \- The patient serves as his own control, n=100 patients with diabetes

Conditions

Interventions

TypeNameDescription
DRUGinsulin detemir3 cutaneous injections
DRUGsaline3 cutaneous injections

Timeline

Start date
2008-01-01
Primary completion
2009-06-01
Completion
2010-07-01
First posted
2008-02-06
Last updated
2012-09-03

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00607737. Inclusion in this directory is not an endorsement.

Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes (NCT00607737) · Clinical Trials Directory